Models:
Joseph Gordon
joseph-gordon/
bc_ml_pub
0
Downloads: 1
[3e731f]: / data / SJS_extval / Supplementary Tables.xlsx

Download this file

# Donor.ID Age T.stage LN.status.at.diagnosis Histology ER.Allred ER.status HER2.status Grade.pre.NAT NAT.regimen Chemo.cycles aHER2.cycles Surgery.type LVI Tumour.dimension.surgery.1 Tumour.dimension.surgery.2 Percent.cellularity Percent.CIS Number.of.LN.removed Number.of.positive.LN Max.LN.met.size RCB.score RCB.category pCR.RD PAM50 iC10 DNA.sequenced RNA.sequenced Digital.pathology
1 T001 51 T2 NEG IDC 8 POS POS 3 FEC-T + Trastuzumab 6 3.0 Mastectomy NO 3.0 2.0 5.0 0.0 1.0 0.0 0.0 0.98 RCB-I RD Her2 5 YES YES YES
2 T002 42 T4 POS IDC 7 POS NEG 2 T-FEC 6 nan Mastectomy NO 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 pCR pCR Basal 10 YES YES YES
3 T003 36 T2 NEG IDC 8 POS POS 2 FEC-T + Trastuzumab 6 2.0 WLE NO 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 pCR pCR LumB 9 YES YES YES
4 T004 33 T3 NEG IDC 4 POS NEG 3 FEC-T 6 nan Mastectomy NO 16.0 10.0 80.0 0.0 6.0 0.0 0.0 2.075 RCB-II RD Basal 10 YES YES YES
5 T005 49 T3 POS IDC 8 POS NEG 3 FEC-T 6 nan Mastectomy YES 15.0 9.0 5.0 0.0 15.0 5.0 5.0 2.866 RCB-II RD LumB 6 YES YES YES
6 T006 46 T2 POS IDC 7 POS NEG 3 T-FEC 6 nan WLE NO 18.0 13.0 50.0 0.0 13.0 3.0 7.0 3.584 RCB-III RD LumB 7 YES YES YES
7 T007 42 T2 NEG IDC 6 POS POS 2 FEC-T + Trastuzumab 6 2.0 WLE NO 21.0 12.0 5.0 30.0 1.0 0.0 0.0 1.267 RCB-I RD Her2 5 YES YES YES
8 T008 50 T3 POS IDC 0 NEG NEG 3 T-FEC 6 nan Mastectomy NO 6.0 0.1 1.0 0.0 16.0 4.0 2.0 1.948 RCB-II RD Basal 4 YES YES YES
9 T009 53 T2 POS IDC 8 POS POS 2 FEC-T + Trastuzumab 6 2.0 Mastectomy YES 0.0 0.0 0.0 0.0 19.0 1.0 0.1 0.676 RCB-I RD Her2 5 YES YES YES
10 T010 56 T2 NEG IDC+MUCINOUS 8 POS POS 2 FEC-T + Trastuzumab 6 2.0 Mastectomy NO 16.0 14.0 30.0 0.0 8.0 0.0 0.0 1.807 RCB-II RD LumB 6 YES YES YES
11 T011 53 T3 POS IDC 8 POS POS 3 FEC-T + Trastuzumab 6 2.0 Mastectomy NO 8.0 5.0 1.0 0.0 7.0 0.0 0.0 0.876 RCB-I RD Her2 5 YES YES YES
12 T012 33 T4 POS IDC 3 POS NEG 3 T-FEC 6 nan Mastectomy NO 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 pCR pCR Basal 10 YES YES YES
13 T013 33 T2 NEG IDC 4 POS NEG 3 T-FEC 6 nan Mastectomy NO 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 pCR pCR Basal 10 YES YES YES
14 T014 40 T2 NEG IDC 8 POS POS 3 FEC-T + Trastuzumab 6 3.0 WLE NO 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 pCR pCR Her2 5 YES YES YES
15 T015 57 T2 NEG IDC 0 NEG NEG 3 T-FEC 6 nan WLE NO 5.0 3.0 40.0 0.0 1.0 0.0 0.0 1.508 RCB-II RD Basal 10 YES YES YES
16 T016 56 T3 POS ILC 8 POS NEG 2 T-FEC 6 nan Mastectomy NO 180.0 44.0 15.0 0.0 22.0 2.0 9.0 3.773 RCB-III RD LumA 2 YES YES YES
17 T017 46 T3 POS IDC 8 POS NEG 3 T-FEC 6 nan Mastectomy YES 70.0 24.0 0.1 0.0 12.0 5.0 5.0 2.403 RCB-II RD Normal 7 YES YES YES
18 T018 47 T3 POS IDC 0 NEG NEG 2 T-FEC 6 nan Mastectomy YES 50.0 25.0 1.0 0.0 13.0 3.0 4.0 2.633 RCB-II RD Normal 3 YES YES YES
19 T019 59 T2 POS IDC 8 POS NEG 2 T-FEC 6 nan Mastectomy NO 100.0 45.0 5.0 0.0 14.0 5.0 6.0 3.359 RCB-III RD Unk 6 YES NO YES
20 T020 34 T1 NEG IDC 8 POS POS 3 FEC-T + Trastuzumab 6 2.0 WLE NO 8.0 4.0 0.1 0.0 1.0 0.0 0.0 0.581 RCB-I RD LumB 5 YES YES YES
21 T022 42 T2 POS IDC 2 NEG POS 2 FEC-T + Trastuzumab 6 2.0 WLE NO 0.0 0.0 0.0 0.0 20.0 0.0 0.0 0.0 pCR pCR Her2 5 YES YES YES
22 T023 39 T2 POS IDC 8 POS NEG 2 T-FEC 6 nan Mastectomy YES 22.0 11.0 2.0 0.0 47.0 2.0 3.0 2.474 RCB-II RD LumA 8 YES YES YES
23 T024 27 T2 NEG IDC 0 NEG NEG 3 T-FEC 6 nan WLE NO 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 pCR pCR Basal 10 YES YES YES
24 T025 62 T2 POS IDC 8 POS NEG 2 T-FEC 6 nan WLE NO 15.0 14.0 50.0 0.0 16.0 6.0 12.0 3.828 RCB-III RD LumA 8 YES YES YES
25 T026 32 T2 NEG MEDULLARY 3 POS NEG 3 T-FEC 6 nan WLE NO 3.0 2.0 80.0 0.0 4.0 0.0 0.0 1.57 RCB-II RD Basal 10 YES YES YES
26 T027 52 T2 NEG IDC 8 POS NEG 2 TC 4 nan Mastectomy NO 23.0 nan nan nan 1.0 0.0 nan nan nan nan LumA 8 YES YES YES
27 T028 37 T3 POS IDC 4 POS POS 3 FEC-T + Trastuzumab 6 2.0 Mastectomy NO 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 pCR pCR Her2 5 YES YES YES
28 T029 53 T2 NEG IDC 8 POS POS 3 FEC-T + Trastuzumab 6 2.0 WLE NO 27.0 10.0 60.0 0.0 1.0 0.0 0.0 2.066 RCB-II RD LumB 9 YES YES YES
29 T030 48 T3 NEG IDC 8 POS NEG 2 T-FEC 6 nan Mastectomy NO 33.0 16.0 10.0 0.0 2.0 0.0 0.0 1.613 RCB-II RD LumA 7 YES YES YES
30 T031 51 T1 NEG IDC 0 NEG POS 3 FEC-T + Trastuzumab 6 3.0 WLE NO 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 pCR pCR Normal 4 YES YES YES
31 T032 69 T2 NEG IDC 0 NEG NEG 3 T-FEC 6 nan WLE NO 9.0 5.0 50.0 0.0 2.0 0.0 0.0 1.72 RCB-II RD Basal 4 YES YES YES
32 T033 49 T2 NEG IDC 0 NEG NEG 3 T-FEC 6 nan WLE NO 1.0 1.0 95.0 0.0 1.0 0.0 0.0 1.388 RCB-II RD Basal 3 YES YES YES
33 T035 33 T2 NEG IDC 0 NEG NEG 3 T-FEC 6 nan WLE NO 3.0 2.0 90.0 0.0 5.0 0.0 0.0 1.601 RCB-II RD Basal 10 YES YES YES
34 T036 54 T1 POS IDC 3 POS NEG 3 T-FEC 6 nan WLE NO 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 pCR pCR Her2 4 YES YES YES
35 T037 49 T2 NEG IDC 1 NEG NEG 3 T-FEC 6 nan WLE NO 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 pCR pCR Basal 10 YES YES YES
36 T038 41 T2 NEG IDC 0 NEG NEG 2 T-FEC 6 nan Mastectomy NO 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 pCR pCR Basal 10 YES YES YES
37 T039 51 T2 POS IDC 8 POS NEG 2 T-FEC 6 nan WLE NO 6.0 4.0 20.0 40.0 24.0 0.0 0.0 1.279 RCB-I RD LumA 8 YES YES YES
38 T040 34 T2 NEG IDC 0 NEG NEG 3 T-FEC 6 nan Mastectomy NO 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 pCR pCR Basal 10 YES YES YES
39 T041 44 T2 NEG IDC 8 POS NEG 3 T-FEC 6 nan WLE YES 14.0 11.0 80.0 0.0 5.0 0.0 0.0 2.068 RCB-II RD LumB 2 YES YES YES
40 T042 57 T3 NEG IDC 0 NEG NEG 3 T 2 nan Mastectomy NO 4.0 0.5 5.0 0.0 20.0 0.0 0.0 0.892 RCB-I RD Basal 9 YES YES YES
41 T043 54 T2 POS IDC 8 POS NEG 2 T-FEC 5 nan Mastectomy YES 18.0 17.0 40.0 0.0 13.0 2.0 13.0 3.65 RCB-III RD LumB 6 YES YES YES
42 T044 40 T2 POS IDC 8 POS NEG 3 T-FEC 6 nan Mastectomy YES 18.0 10.0 40.0 50.0 14.0 11.0 10.0 3.514 RCB-III RD LumB 2 YES YES YES
43 T045 41 T2 POS IDC 8 POS NEG 3 T-FEC 6 nan Mastectomy NO 27.0 9.0 0.1 0.0 12.0 0.0 0.0 0.69 RCB-I RD LumA 8 YES YES YES
44 T046 65 T1 POS IDC 8 POS NEG 3 T-EC 6 nan WLE NO 5.0 4.0 25.0 0.0 10.0 2.0 5.0 2.873 RCB-II RD LumB 1 YES YES YES
45 T047 58 T3 NEG IDC 8 POS NEG 2 T-FEC 6 nan WLE NO 41.0 37.0 30.0 2.0 2.0 1.0 0.1 2.795 RCB-II RD LumA 8 YES YES YES
46 T048 66 T2 NEG IDC 8 POS POS 2 FEC-T + Trastuzumab 6 3.0 WLE NO 18.0 15.0 5.0 0.0 3.0 0.0 0.0 1.354 RCB-I RD LumB 5 YES YES YES
47 T049 37 T2 POS IDC 7 POS POS 3 FEC-T + Trastuzumab 6 2.0 WLE NO 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 pCR pCR Her2 9 YES YES YES
48 T050 60 T3 POS IDC 8 POS POS 2 EC-T + Trastuzumab 6 3.0 Mastectomy NO 26.0 10.0 5.0 0.0 23.0 11.0 32.0 3.615 RCB-III RD LumB 7 YES YES YES
49 T051 46 T2 NEG IDC 8 POS NEG 2 T-FEC 6 nan WLE NO 31.0 15.0 10.0 0.0 1.0 0.0 0.0 1.595 RCB-II RD LumB 8 YES YES YES
50 T052 35 T2 NEG IDC 0 NEG NEG 3 T-FEC 6 nan WLE YES 0.0 0.0 0.0 0.0 14.0 1.0 0.7 0.941 RCB-I RD Basal 9 YES YES YES
51 T053 46 T3 POS ILC 8 POS NEG 2 T-FEC 6 nan WLE NO 34.0 30.0 10.0 0.0 14.0 4.0 9.0 3.429 RCB-III RD Unk 3 YES NO YES
52 T054 51 T1 NEG IDC 0 NEG NEG 3 TC 4 nan WLE NO 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 pCR pCR Basal 10 YES YES YES
53 T055 63 T2 POS IDC 5 POS POS 3 FEC-T + Trastuzumab 6 3.0 WLE NO 6.0 4.0 5.0 0.0 14.0 1.0 4.0 2.368 RCB-II RD Unk 5 YES NO YES
54 T056 55 T2 NEG IDC 0 NEG NEG 2 T-FEC 6 nan WLE NO 12.0 7.0 70.0 0.0 2.0 0.0 0.0 1.92 RCB-II RD Normal 4 YES YES YES
55 T057 42 T2 NEG IDC 0 NEG NEG 3 T-FEC 6 nan WLE NO 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 pCR pCR Basal 9 YES YES YES
56 T058 24 T3 POS IDC 8 POS NEG 2 T-FEC 6 nan Mastectomy YES 100.0 36.0 50.0 0.0 22.0 12.0 3.0 4.013 RCB-III RD LumB 8 YES YES YES
57 T059 52 T1 NEG IDC 6 POS POS 3 FEC-T + Trastuzumab 6 2.0 WLE NO 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 pCR pCR Her2 5 YES YES YES
58 T060 67 T2 POS IDC 8 POS NEG 3 T-FEC 6 nan Mastectomy NO 3.0 2.0 10.0 0.0 17.0 3.0 0.1 1.882 RCB-II RD LumB 2 YES YES YES
59 T061 53 T2 POS IDC 8 POS NEG 2 FEC-T 6 nan WLE NO 15.0 12.0 70.0 5.0 9.0 1.0 5.0 3.346 RCB-III RD LumA 8 YES YES YES
60 T062 64 T3 POS IDC 8 POS NEG 3 T-FEC 6 nan WLE YES 32.0 23.0 10.0 5.0 17.0 4.0 6.0 3.253 RCB-II RD LumB 1 YES YES YES
61 T064 61 T2 NEG IDC 3 POS POS 3 FEC-T + Trastuzumab 6 2.0 WLE NO 1.0 0.8 90.0 0.0 3.0 0.0 0.0 1.349 RCB-I RD Her2 5 YES YES YES
62 T065 63 T3 POS ILC 0 NEG NEG 2 T-Carboplatin 6 nan Mastectomy NO 55.0 43.0 10.0 0.0 17.0 6.0 4.0 3.382 RCB-III RD Basal 10 YES YES YES
63 T066 52 T4 POS IDC 8 POS NEG 2 T-FEC 6 nan WLE NO 25.0 11.0 1.0 0.0 13.0 9.0 7.0 2.77 RCB-II RD LumB 1 YES YES YES
64 T067 48 T2 POS IDC 8 POS NEG 2 T-FEC 6 nan WLE YES 15.0 13.0 10.0 2.0 18.0 7.0 3.0 2.966 RCB-II RD LumA 8 YES YES YES
65 T068 61 T4 POS IDC 8 POS NEG 2 T-FEC 6 nan Mastectomy YES 130.0 48.0 5.0 5.0 32.0 20.0 9.0 3.591 RCB-III RD LumA 6 YES YES YES
66 T069 65 T3 POS IDC+MUCINOUS 8 POS POS 3 FEC-T + Trastuzumab 5 1.0 Mastectomy NO 30.0 16.0 1.0 10.0 9.0 0.0 0.0 1.062 RCB-I RD LumA 5 YES YES YES
67 T070 63 T2 POS IDC 7 POS NEG 3 FEC-T 6 nan WLE NO 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 pCR pCR Basal 9 YES YES YES
68 T071 35 T2 POS IDC 0 NEG NEG 3 T-FEC 6 nan Mastectomy NO 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 pCR pCR Basal 10 YES YES YES
69 T072 53 T2 POS IDC+ILC 8 POS NEG 2 T-FEC 6 nan Mastectomy YES 70.0 26.0 10.0 10.0 18.0 2.0 4.0 3.152 RCB-II RD LumA 2 YES YES YES
70 T073 38 T3 NEG IDC 8 POS POS 3 FEC-T + Trastuzumab 6 3.0 Mastectomy NO 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 pCR pCR Her2 5 YES YES YES
71 T074 50 T2 POS IDC 8 POS NEG 2 FEC-T 6 nan WLE NO 17.0 11.0 15.0 40.0 10.0 0.0 0.0 1.45 RCB-II RD LumB 6 YES YES YES
72 T075 52 T2 POS IDC 8 POS NEG 2 T-FEC 6 nan Mastectomy NO 3.0 1.0 20.0 0.0 15.0 0.0 0.0 1.169 RCB-I RD Unk 9 YES NO YES
73 T076 54 T2 NEG IDC 0 NEG POS 2 FEC-T + Trastuzumab 6 3.0 WLE NO 1.0 0.5 10.0 0.0 2.0 0.0 0.0 0.892 RCB-I RD Normal 4 YES YES YES
74 T077 48 T2 NEG IDC 8 POS POS 3 FEC-T + Trastuzumab 6 1.0 WLE NO 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 pCR pCR Unk 5 YES YES YES
75 T078 50 T3 NEG IDC 7 POS POS 3 FEC-T + Trastuzumab 6 3.0 Mastectomy NO 0.0 0.0 0.0 0.0 10.0 2.0 6.0 1.491 RCB-II RD Her2 2 YES YES YES
76 T079 59 T2 NEG IDC 0 NEG NEG 2 T-FEC 6 nan Mastectomy NO 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 pCR pCR Basal 10 YES YES YES
77 T080 50 T3 POS IDC 7 POS POS 3 FEC-T + Trastuzumab 6 2.0 WLE NO 0.0 0.0 0.0 0.0 10.0 7.0 7.0 1.72 RCB-II RD Her2 5 YES YES YES
78 T081 39 T2 NEG IDC 0 NEG NEG 3 T-FEC 6 nan Mastectomy NO 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 pCR pCR Basal 10 YES YES NO
79 T083 48 T3 NEG IDC 8 POS POS 3 FEC-T + Trastuzumab 6 3.0 Mastectomy NO 10.0 2.0 10.0 99.0 2.0 0.0 0.0 0.558 RCB-I RD LumB 5 YES YES YES
80 T086 63 T2 NEG IDC 0 NEG NEG 3 T-FEC 6 nan WLE NO 2.0 1.0 10.0 0.0 10.0 1.0 2.0 2.129 RCB-II RD Her2 4 YES YES YES
81 T087 56 T2 POS IDC 8 POS POS 3 FEC-T + Trastuzumab 6 3.0 Mastectomy NO 50.0 31.0 15.0 5.0 11.0 1.0 0.1 2.553 RCB-II RD LumA 9 YES YES YES
82 T088 67 T2 NEG IDC 8 POS POS 2 TC + Trastuzumab 4 2.0 nan nan nan nan nan nan nan nan nan nan nan nan LumB 1 YES YES YES
83 T089 33 T4 POS IDC 0 NEG NEG 3 EC-T 5 nan Mastectomy NO 100.0 44.0 20.0 2.0 13.0 1.0 1.0 3.165 RCB-II RD Basal 10 YES YES YES
84 T090 49 T2 NEG IDC 0 NEG NEG 3 T-FEC 6 nan WLE NO 14.0 8.0 10.0 0.0 5.0 0.0 0.0 1.414 RCB-II RD Normal 4 YES YES YES
85 T091 45 T2 NEG IDC 8 POS NEG 3 T-FEC 6 nan WLE NO 14.0 10.0 50.0 10.0 3.0 0.0 0.0 1.86 RCB-II RD Unk 6 YES NO YES
86 T092 53 T2 POS IDC 0 NEG POS 3 FEC-T + Trastuzumab 6 3.0 WLE YES 12.0 4.0 5.0 0.0 27.0 0.0 0.0 1.169 RCB-I RD Her2 5 YES YES YES
87 T093 48 T2 NEG IDC 8 POS NEG 3 T-FEC 6 nan WLE YES 6.0 5.0 80.0 0.0 3.0 2.0 0.2 2.636 RCB-II RD LumB 6 YES YES YES
88 T094 35 T2 POS IDC 0 NEG NEG 3 T-FEC 6 nan WLE NO 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 pCR pCR Basal 9 YES YES YES
89 T095 53 T2 NEG APOCRINE 0 NEG POS 2 FEC-T + Trastuzumab 6 2.0 WLE NO 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 pCR pCR Her2 5 YES YES YES
90 T096 59 T2 POS ILC 8 POS NEG 2 T-FEC 6 nan Mastectomy NO 65.0 38.0 20.0 0.5 23.0 21.0 8.0 3.869 RCB-III RD LumA 2 YES YES YES
91 T097 56 T1 NEG IDC 0 NEG POS 3 TC + Trastuzumab 4 2.0 Mastectomy NO 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 pCR pCR Her2 5 YES YES YES
92 T098 37 T2 NEG IDC 8 POS POS 2 FEC-T + Trastuzumab 6 3.0 WLE NO 30.0 21.0 30.0 20.0 3.0 1.0 3.0 3.105 RCB-II RD LumA 4 YES YES YES
93 T099 62 T3 NEG IDC 8 POS POS 2 FEC-T + Trastuzumab + Pertuzumab 6 3.0 Mastectomy NO 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 pCR pCR LumB 5 YES YES YES
94 T100 57 T3 NEG IDC 0 NEG POS 3 FEC-T + Trastuzumab 6 3.0 Mastectomy NO 2.0 1.0 5.0 0.0 5.0 0.0 0.0 0.892 RCB-I RD Her2 5 YES YES YES
95 T101 74 T2 POS IDC 0 NEG NEG 3 TC 4 nan WLE NO 17.0 12.0 40.0 30.0 12.0 1.0 9.0 3.225 RCB-II RD Basal 9 YES YES YES
96 T102 65 T2 POS IDC 8 POS NEG 3 TC 1 nan Mastectomy NO 19.0 10.0 60.0 1.0 17.0 2.0 12.0 3.679 RCB-III RD LumB 6 YES YES YES
97 T103 55 T2 NEG MEDULLARY 0 NEG NEG 3 T-FEC 6 nan WLE NO 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 pCR pCR Basal 10 YES YES YES
98 T104 53 T2 POS IDC 0 NEG NEG 3 T-FEC 6 nan WLE NO 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 pCR pCR Her2 2 YES YES YES
99 T105 43 T3 NEG IDC 8 POS POS 3 FEC-T + Trastuzumab 6 3.0 Mastectomy NO 11.0 6.0 2.0 0.0 4.0 0.0 0.0 1.028 RCB-I RD Her2 5 YES YES YES
100 T106 39 T4 POS IDC 8 POS NEG 3 T 3 nan nan nan nan nan nan nan nan nan nan nan nan nan LumB 1 YES YES YES